##fileformat=VCFv4.2
##FORMAT=<ID=CN,Number=1,Type=Integer,Description="Predicted copy state">
##FORMAT=<ID=CNQ,Number=1,Type=Integer,Description="Read-depth genotype quality">
##FORMAT=<ID=EV,Number=.,Type=String,Description="Classes of evidence supporting final genotype">
##FORMAT=<ID=GQ,Number=1,Type=Integer,Description="Genotype Quality">
##FORMAT=<ID=GT,Number=1,Type=String,Description="Genotype">
##FORMAT=<ID=PE_GQ,Number=1,Type=Integer,Description="Paired-end genotype quality">
##FORMAT=<ID=PE_GT,Number=1,Type=Integer,Description="Paired-end genotype">
##FORMAT=<ID=RD_CN,Number=1,Type=Integer,Description="Predicted copy state">
##FORMAT=<ID=RD_GQ,Number=1,Type=Integer,Description="Read-depth genotype quality">
##FORMAT=<ID=SR_GQ,Number=1,Type=Integer,Description="Split read genotype quality">
##FORMAT=<ID=SR_GT,Number=1,Type=Integer,Description="Split-read genotype">
##INFO=<ID=ALGORITHMS,Number=.,Type=String,Description="Source algorithms">
##INFO=<ID=CHR2,Number=1,Type=String,Description="Chromosome for END coordinate">
##INFO=<ID=CPX_INTERVALS,Number=.,Type=String,Description="Genomic intervals constituting complex variant.">
##INFO=<ID=CPX_TYPE,Number=1,Type=String,Description="Class of complex variant.">
##INFO=<ID=END,Number=1,Type=Integer,Description="End position of the structural variant">
##INFO=<ID=END2,Number=1,Type=Integer,Description="Position of breakpoint on CHR2">
##INFO=<ID=EVIDENCE,Number=.,Type=String,Description="Classes of random forest support.">
##INFO=<ID=SOURCE,Number=1,Type=String,Description="Source of inserted sequence.">
##INFO=<ID=STRANDS,Number=1,Type=String,Description="Breakpoint strandedness [++,+-,-+,--]">
##INFO=<ID=SVLEN,Number=1,Type=Integer,Description="SV length">
##INFO=<ID=SVTYPE,Number=1,Type=String,Description="Type of structural variant">
##INFO=<ID=UNRESOLVED_TYPE,Number=1,Type=String,Description="Class of unresolved variant.">
##INFO=<ID=PREDICTED_BREAKEND_EXONIC,Number=.,Type=String,Description="Gene(s) for which the SV breakend is predicted to fall in an exon.">
##INFO=<ID=PREDICTED_COPY_GAIN,Number=.,Type=String,Description="Gene(s) on which the SV is predicted to have a copy-gain effect.">
##INFO=<ID=PREDICTED_DUP_PARTIAL,Number=.,Type=String,Description="Gene(s) which are partially overlapped by an SV's duplication, but the transcription start site is not duplicated.">
##INFO=<ID=PREDICTED_INTERGENIC,Number=0,Type=Flag,Description="SV does not overlap any protein-coding genes.">
##INFO=<ID=PREDICTED_INTRAGENIC_EXON_DUP,Number=.,Type=String,Description="Gene(s) on which the SV is predicted to result in intragenic exonic duplication without breaking any coding sequences.">
##INFO=<ID=PREDICTED_INTRONIC,Number=.,Type=String,Description="Gene(s) where the SV was found to lie entirely within an intron.">
##INFO=<ID=PREDICTED_INV_SPAN,Number=.,Type=String,Description="Gene(s) which are entirely spanned by an SV's inversion.">
##INFO=<ID=PREDICTED_LOF,Number=.,Type=String,Description="Gene(s) on which the SV is predicted to have a loss-of-function effect.">
##INFO=<ID=PREDICTED_MSV_EXON_OVERLAP,Number=.,Type=String,Description="Gene(s) on which the multiallelic SV would be predicted to have a LOF, INTRAGENIC_EXON_DUP, COPY_GAIN, DUP_PARTIAL, TSS_DUP, or PARTIAL_EXON_DUP annotation if the SV were biallelic.">
##INFO=<ID=PREDICTED_NEAREST_TSS,Number=.,Type=String,Description="Nearest transcription start site to an intergenic variant.">
##INFO=<ID=PREDICTED_NONCODING_BREAKPOINT,Number=.,Type=String,Description="Class(es) of noncoding elements disrupted by SV breakpoint.">
##INFO=<ID=PREDICTED_NONCODING_SPAN,Number=.,Type=String,Description="Class(es) of noncoding elements spanned by SV.">
##INFO=<ID=PREDICTED_PARTIAL_EXON_DUP,Number=.,Type=String,Description="Gene(s) where the duplication SV has one breakpoint in the coding sequence.">
##INFO=<ID=PREDICTED_PROMOTER,Number=.,Type=String,Description="Gene(s) for which the SV is predicted to overlap the promoter region.">
##INFO=<ID=PREDICTED_TSS_DUP,Number=.,Type=String,Description="Gene(s) for which the SV is predicted to duplicate the transcription start site.">
##INFO=<ID=PREDICTED_UTR,Number=.,Type=String,Description="Gene(s) for which the SV is predicted to disrupt a UTR.">
##INFO=<ID=AN,Number=1,Type=Integer,Description="Total number of alleles genotyped (for biallelic sites) or individuals with copy-state estimates (for multiallelic sites).">
##INFO=<ID=AC,Number=A,Type=Integer,Description="Number of non-reference alleles observed (for biallelic sites) or individuals at each copy state (for multiallelic sites).">
##INFO=<ID=AF,Number=A,Type=Float,Description="Allele frequency (for biallelic sites) or copy-state frequency (for multiallelic sites).">
##INFO=<ID=N_BI_GENOS,Number=1,Type=Integer,Description="Total number of individuals with complete genotypes (biallelic sites only).">
##INFO=<ID=N_HOMREF,Number=1,Type=Integer,Description="Number of individuals with homozygous reference genotypes (biallelic sites only).">
##INFO=<ID=N_HET,Number=1,Type=Integer,Description="Number of individuals with heterozygous genotypes (biallelic sites only).">
##INFO=<ID=N_HOMALT,Number=1,Type=Integer,Description="Number of individuals with homozygous alternate genotypes (biallelic sites only).">
##INFO=<ID=FREQ_HOMREF,Number=1,Type=Float,Description="Homozygous reference genotype frequency (biallelic sites only).">
##INFO=<ID=FREQ_HET,Number=1,Type=Float,Description="Heterozygous genotype frequency (biallelic sites only).">
##INFO=<ID=FREQ_HOMALT,Number=1,Type=Float,Description="Homozygous alternate genotype frequency (biallelic sites only).">
##INFO=<ID=MALE_AN,Number=1,Type=Integer,Description="Total number of MALE alleles genotyped (for biallelic sites) or MALE individuals with copy-state estimates (for multiallelic sites).">
##INFO=<ID=MALE_AC,Number=A,Type=Integer,Description="Number of non-reference MALE alleles observed (for biallelic sites) or MALE individuals at each copy state (for multiallelic sites).">
##INFO=<ID=MALE_AF,Number=A,Type=Float,Description="MALE allele frequency (for biallelic sites) or MALE copy-state frequency (for multiallelic sites).">
##INFO=<ID=MALE_N_BI_GENOS,Number=1,Type=Integer,Description="Total number of MALE individuals with complete genotypes (biallelic sites only).">
##INFO=<ID=MALE_N_HOMREF,Number=1,Type=Integer,Description="Number of MALE individuals with homozygous reference genotypes (biallelic sites only).">
##INFO=<ID=MALE_N_HET,Number=1,Type=Integer,Description="Number of MALE individuals with heterozygous genotypes (biallelic sites only).">
##INFO=<ID=MALE_N_HOMALT,Number=1,Type=Integer,Description="Number of MALE individuals with homozygous alternate genotypes (biallelic sites only).">
##INFO=<ID=MALE_FREQ_HOMREF,Number=1,Type=Float,Description="MALE homozygous reference genotype frequency (biallelic sites only).">
##INFO=<ID=MALE_FREQ_HET,Number=1,Type=Float,Description="MALE heterozygous genotype frequency (biallelic sites only).">
##INFO=<ID=MALE_FREQ_HOMALT,Number=1,Type=Float,Description="MALE homozygous alternate genotype frequency (biallelic sites only).">
##INFO=<ID=FEMALE_AN,Number=1,Type=Integer,Description="Total number of FEMALE alleles genotyped (for biallelic sites) or FEMALE individuals with copy-state estimates (for multiallelic sites).">
##INFO=<ID=FEMALE_AC,Number=A,Type=Integer,Description="Number of non-reference FEMALE alleles observed (for biallelic sites) or FEMALE individuals at each copy state (for multiallelic sites).">
##INFO=<ID=FEMALE_AF,Number=A,Type=Float,Description="FEMALE allele frequency (for biallelic sites) or FEMALE copy-state frequency (for multiallelic sites).">
##INFO=<ID=FEMALE_N_BI_GENOS,Number=1,Type=Integer,Description="Total number of FEMALE individuals with complete genotypes (biallelic sites only).">
##INFO=<ID=FEMALE_N_HOMREF,Number=1,Type=Integer,Description="Number of FEMALE individuals with homozygous reference genotypes (biallelic sites only).">
##INFO=<ID=FEMALE_N_HET,Number=1,Type=Integer,Description="Number of FEMALE individuals with heterozygous genotypes (biallelic sites only).">
##INFO=<ID=FEMALE_N_HOMALT,Number=1,Type=Integer,Description="Number of FEMALE individuals with homozygous alternate genotypes (biallelic sites only).">
##INFO=<ID=FEMALE_FREQ_HOMREF,Number=1,Type=Float,Description="FEMALE homozygous reference genotype frequency (biallelic sites only).">
##INFO=<ID=FEMALE_FREQ_HET,Number=1,Type=Float,Description="FEMALE heterozygous genotype frequency (biallelic sites only).">
##INFO=<ID=FEMALE_FREQ_HOMALT,Number=1,Type=Float,Description="FEMALE homozygous alternate genotype frequency (biallelic sites only).">
##INFO=<ID=gnomAD_V2_SVID,Number=1,Type=String,Description="Allele frequency (for biallelic sites) or copy-state frequency (for multiallelic sites) of an overlapping event in gnomad.">
##INFO=<ID=gnomAD_V2_AF,Number=1,Type=Float,Description="Allele frequency (for biallelic sites) or copy-state frequency (for multiallelic sites) of an overlapping event in gnomad.">
##INFO=<ID=gnomAD_V2_AC,Number=1,Type=Float,Description="Allele frequency (for biallelic sites) or copy-state frequency (for multiallelic sites) of an overlapping event in gnomad.">
##INFO=<ID=gnomAD_V2_AN,Number=1,Type=Float,Description="Allele frequency (for biallelic sites) or copy-state frequency (for multiallelic sites) of an overlapping event in gnomad.">
##INFO=<ID=StrVCTVRE,Number=1,Type=String,Description="StrVCTVRE score">
##FORMAT=<ID=CONC_ST,Number=.,Type=String,Description="The genotype concordance contingency state">
#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO	FORMAT	RGP_164_1	RGP_164_2	RGP_164_3	RGP_164_4	RGP_164_5
chr1	180928	BND_chr1_6	N	<BND>	657	HIGH_SR_BACKGROUND;UNRESOLVED	ALGORITHMS=manta;CHR2=chr5;END=180928;END2=20404;EVIDENCE=PE,SR;PREDICTED_INTERGENIC;PREDICTED_NEAREST_TSS=OR4F5,PLEKHG4B;PREDICTED_NONCODING_BREAKPOINT=DNase;STRANDS=+-;SVLEN=-1;SVTYPE=BND;UNRESOLVED_TYPE=SINGLE_ENDER_+-;AN=8;AC=1;AF=0.04775;N_BI_GENOS=2911;N_HOMREF=2633;N_HET=278;N_HOMALT=0;FREQ_HOMREF=0.9045;FREQ_HET=0.0954998;FREQ_HOMALT=0;MALE_AN=2894;MALE_AC=137;MALE_AF=0.047339;MALE_N_BI_GENOS=1447;MALE_N_HOMREF=1310;MALE_N_HET=137;MALE_N_HOMALT=0;MALE_FREQ_HOMREF=0.905321;MALE_FREQ_HET=0.0946786;MALE_FREQ_HOMALT=0;FEMALE_AN=2906;FEMALE_AC=139;FEMALE_AF=0.047832;FEMALE_N_BI_GENOS=1453;FEMALE_N_HOMREF=1314;FEMALE_N_HET=139;FEMALE_N_HOMALT=0;FEMALE_FREQ_HOMREF=0.904336;FEMALE_FREQ_HET=0.0956641;FEMALE_FREQ_HOMALT=0	GT:EV:GQ:PE_GQ:PE_GT:SR_GQ:SR_GT	0/0:PE,SR:99:99:0:2:0	0/1:SR:31:99:0:31:1	0/0:PE,SR:99:99:0:99:0	0/0:PE,SR:99:99:0:2:0	0/0:PE,SR:99:99:0:2:0
chr1	257666	DUP_chr1_5	N	<DUP>	999	PASS	ALGORITHMS=depth;CHR2=chr1;END=263666;EVIDENCE=BAF,RD;PREDICTED_INTERGENIC;PREDICTED_NEAREST_TSS=OR4F29;SVLEN=6000;SVTYPE=DUP;AN=8;AC=1;AF=0.115596;N_BI_GENOS=2911;N_HOMREF=2348;N_HET=453;N_HOMALT=110;FREQ_HOMREF=0.806596;FREQ_HET=0.155617;FREQ_HOMALT=0.0377877;MALE_AN=2894;MALE_AC=339;MALE_AF=0.117139;MALE_N_BI_GENOS=1447;MALE_N_HOMREF=1163;MALE_N_HET=229;MALE_N_HOMALT=55;MALE_FREQ_HOMREF=0.803732;MALE_FREQ_HET=0.158258;MALE_FREQ_HOMALT=0.0380097;FEMALE_AN=2906;FEMALE_AC=330;FEMALE_AF=0.113558;FEMALE_N_BI_GENOS=1453;FEMALE_N_HOMREF=1178;FEMALE_N_HET=220;FEMALE_N_HOMALT=55;FEMALE_FREQ_HOMREF=0.810736;FEMALE_FREQ_HET=0.151411;FEMALE_FREQ_HOMALT=0.0378527	GT:EV:GQ:RD_CN:RD_GQ	0/0:RD:99:2:99	0/0:RD:99:2:99	0/1:RD:8:3:8	0/0:RD:13:1:13	0/0:RD:13:1:13
chr1	413968	DEL_chr1_12	N	<DEL>	999	PASS	ALGORITHMS=depth;CHR2=chr1;END=428500;EVIDENCE=RD;PREDICTED_INTERGENIC;PREDICTED_NEAREST_TSS=OR4F29;SVLEN=14532;SVTYPE=DEL;AN=8;AC=1;AF=0.064926;N_BI_GENOS=2911;N_HOMREF=2538;N_HET=368;N_HOMALT=5;FREQ_HOMREF=0.871865;FREQ_HET=0.126417;FREQ_HOMALT=0.00171762;MALE_AN=2894;MALE_AC=172;MALE_AF=0.059433;MALE_N_BI_GENOS=1447;MALE_N_HOMREF=1278;MALE_N_HET=166;MALE_N_HOMALT=3;MALE_FREQ_HOMREF=0.883207;MALE_FREQ_HET=0.11472;MALE_FREQ_HOMALT=0.00207325;FEMALE_AN=2906;FEMALE_AC=205;FEMALE_AF=0.070544;FEMALE_N_BI_GENOS=1453;FEMALE_N_HOMREF=1250;FEMALE_N_HET=201;FEMALE_N_HOMALT=2;FEMALE_FREQ_HOMREF=0.860289;FEMALE_FREQ_HET=0.138334;FEMALE_FREQ_HOMALT=0.00137646	GT:EV:GQ:RD_CN:RD_GQ	0/0:RD:12:2:12	0/0:RD:0:2:0	0/1:RD:99:1:99	0/0:RD:2:2:2	0/0:RD:2:2:2
chr1	789481	BND_chr1_9	N	<BND>	999	PESR_GT_OVERDISPERSION;UNRESOLVED	ALGORITHMS=manta;CHR2=chr1;END=789481;EVIDENCE=PE;PREDICTED_INTERGENIC;PREDICTED_NEAREST_TSS=FBXO28,OR4F16;PREDICTED_NONCODING_BREAKPOINT=DNase,Tommerup_TADanno;STRANDS=-+;SVLEN=223225007;SVTYPE=BND;UNRESOLVED_TYPE=SINGLE_ENDER_-+;AN=8;AC=7;AF=0.910684;N_BI_GENOS=2911;N_HOMREF=0;N_HET=520;N_HOMALT=2391;FREQ_HOMREF=0;FREQ_HET=0.178633;FREQ_HOMALT=0.821367;MALE_AN=2894;MALE_AC=2639;MALE_AF=0.911887;MALE_N_BI_GENOS=1447;MALE_N_HOMREF=0;MALE_N_HET=255;MALE_N_HOMALT=1192;MALE_FREQ_HOMREF=0;MALE_FREQ_HET=0.176227;MALE_FREQ_HOMALT=0.823773;FEMALE_AN=2906;FEMALE_AC=2643;FEMALE_AF=0.909498;FEMALE_N_BI_GENOS=1453;FEMALE_N_HOMREF=0;FEMALE_N_HET=263;FEMALE_N_HOMALT=1190;FEMALE_FREQ_HOMREF=0;FEMALE_FREQ_HET=0.181005;FEMALE_FREQ_HOMALT=0.818995	GT:EV:GQ:PE_GQ:PE_GT:SR_GQ:SR_GT	1/1:PE:59:59:2:99:0	1/1:PE:26:26:2:99:0	1/1:PE:39:39:2:99:0	0/1:PE:19:19:1:99:0	0/1:PE:19:19:1:99:0
chr1	4228405	INS_chr1_65	N	<INS:ME:ALU>	605	HIGH_SR_BACKGROUND	ALGORITHMS=manta,melt;CHR2=chr1;END=4228448;EVIDENCE=SR;gnomAD_V2_SVID=gnomAD-SV_v2.1_INS_chr1_65;gnomAD_V2_AF=0.068962998688221;gnomAD_V2_AC=224;gnomAD_V2_AN=3247;StrVCTVRE=0.1255;PREDICTED_INTERGENIC;PREDICTED_NEAREST_TSS=C1orf174;SVLEN=298;SVTYPE=INS;AN=8;AC=1;AF=0.10237;N_BI_GENOS=2911;N_HOMREF=2318;N_HET=590;N_HOMALT=3;FREQ_HOMREF=0.79629;FREQ_HET=0.202679;FREQ_HOMALT=0.00103057;MALE_AN=2894;MALE_AC=293;MALE_AF=0.101244;MALE_N_BI_GENOS=1447;MALE_N_HOMREF=1156;MALE_N_HET=289;MALE_N_HOMALT=2;MALE_FREQ_HOMREF=0.798894;MALE_FREQ_HET=0.199724;MALE_FREQ_HOMALT=0.00138217;FEMALE_AN=2906;FEMALE_AC=302;FEMALE_AF=0.103923;FEMALE_N_BI_GENOS=1453;FEMALE_N_HOMREF=1152;FEMALE_N_HET=300;FEMALE_N_HOMALT=1;FEMALE_FREQ_HOMREF=0.792842;FEMALE_FREQ_HET=0.206469;FEMALE_FREQ_HOMALT=0.000688231	GT:EV:GQ:PE_GQ:PE_GT:SR_GQ:SR_GT	0/1:SR:62:99:0:62:1	0/0:PE,SR:99:99:0:99:0	0/0:PE,SR:99:99:0:99:0	0/0:PE,SR:99:99:0:99:0	0/0:PE,SR:99:99:0:99:0
chr1	6558902	CPX_chr1_22	N	<CPX>	644	BOTHSIDES_SUPPORT;HIGH_SR_BACKGROUND	ALGORITHMS=manta;CHR2=chr1;CPX_INTERVALS=INV_chr1:6558902-6559723,DUP_chr1:6559655-6559723;CPX_TYPE=INVdup;END=6559723;EVIDENCE=PE,SR;PREDICTED_INTRONIC=TAS1R1;PREDICTED_NONCODING_BREAKPOINT=Tommerup_TADanno;PREDICTED_NONCODING_SPAN=DNase;SVLEN=821;SVTYPE=CPX;AN=8;AC=2;AF=0.169873;N_BI_GENOS=2911;N_HOMREF=1925;N_HET=983;N_HOMALT=3;FREQ_HOMREF=0.661285;FREQ_HET=0.337685;FREQ_HOMALT=0.00103057;MALE_AN=2894;MALE_AC=497;MALE_AF=0.171735;MALE_N_BI_GENOS=1447;MALE_N_HOMREF=950;MALE_N_HET=497;MALE_N_HOMALT=0;MALE_FREQ_HOMREF=0.656531;MALE_FREQ_HET=0.343469;MALE_FREQ_HOMALT=0;FEMALE_AN=2906;FEMALE_AC=488;FEMALE_AF=0.167928;FEMALE_N_BI_GENOS=1453;FEMALE_N_HOMREF=968;FEMALE_N_HET=482;FEMALE_N_HOMALT=3;FEMALE_FREQ_HOMREF=0.666208;FEMALE_FREQ_HET=0.331727;FEMALE_FREQ_HOMALT=0.00206469	GT:EV:GQ:PE_GQ:PE_GT:SR_GQ:SR_GT:RD_CN:CONC_ST	0/0:PE,SR:99:99:0:99:0:2:EMPTY	0/1:PE,SR:57:0:0:57:1:2:TN,TP	0/1:PE,SR:0:0:1:99:0:2:FP,TN	0/0:PE,SR:99:99:0:0:0:3:FN	1/1:PE,SR:99:99:0:0:0:1:FP,TP
chr1	16088760	CPX_chr1_41	N	<CPX>	684	PASS	ALGORITHMS=manta;CHR2=chr1;CPX_INTERVALS=DUP_chr1:16088760-16088835,INV_chr1:16088760-16089601;CPX_TYPE=dupINV;END=16089601;EVIDENCE=PE,SR;PREDICTED_INTERGENIC;PREDICTED_NEAREST_TSS=FAM131C;PREDICTED_NONCODING_BREAKPOINT=Tommerup_TADanno;PREDICTED_NONCODING_SPAN=DNase;SVLEN=841;SVTYPE=CPX;AN=8;AC=2;AF=0.218138;N_BI_GENOS=2911;N_HOMREF=1659;N_HET=1234;N_HOMALT=18;FREQ_HOMREF=0.569907;FREQ_HET=0.423909;FREQ_HOMALT=0.00618344;MALE_AN=2894;MALE_AC=635;MALE_AF=0.219419;MALE_N_BI_GENOS=1447;MALE_N_HOMREF=818;MALE_N_HET=623;MALE_N_HOMALT=6;MALE_FREQ_HOMREF=0.565308;MALE_FREQ_HET=0.430546;MALE_FREQ_HOMALT=0.00414651;FEMALE_AN=2906;FEMALE_AC=629;FEMALE_AF=0.216449;FEMALE_N_BI_GENOS=1453;FEMALE_N_HOMREF=836;FEMALE_N_HET=605;FEMALE_N_HOMALT=12;FEMALE_FREQ_HOMREF=0.575361;FEMALE_FREQ_HET=0.41638;FEMALE_FREQ_HOMALT=0.00825877	GT:EV:GQ:PE_GQ:PE_GT:SR_GQ:SR_GT	0/1:SR:52:0:0:52:1	0/0:PE,SR:99:99:0:99:0	0/0:PE,SR:99:99:0:99:0	0/1:SR:62:0:0:62:1	0/1:SR:62:0:0:62:1
chr1	17465707	INS_chr1_268	N	<INS:ME:SVA>	263	HIGH_SR_BACKGROUND	ALGORITHMS=melt;CHR2=chr1;END=17465723;EVIDENCE=SR;PREDICTED_INTERGENIC;PREDICTED_NEAREST_TSS=RCC2;PREDICTED_NONCODING_BREAKPOINT=Tommerup_TADanno;SVLEN=955;SVTYPE=INS;AN=8;AC=1;AF=0.004466;N_BI_GENOS=2911;N_HOMREF=2885;N_HET=26;N_HOMALT=0;FREQ_HOMREF=0.991068;FREQ_HET=0.00893164;FREQ_HOMALT=0;MALE_AN=2894;MALE_AC=14;MALE_AF=0.004838;MALE_N_BI_GENOS=1447;MALE_N_HOMREF=1433;MALE_N_HET=14;MALE_N_HOMALT=0;MALE_FREQ_HOMREF=0.990325;MALE_FREQ_HET=0.00967519;MALE_FREQ_HOMALT=0;FEMALE_AN=2906;FEMALE_AC=11;FEMALE_AF=0.003785;FEMALE_N_BI_GENOS=1453;FEMALE_N_HOMREF=1442;FEMALE_N_HET=11;FEMALE_N_HOMALT=0;FEMALE_FREQ_HOMREF=0.992429;FEMALE_FREQ_HET=0.00757054;FEMALE_FREQ_HOMALT=0	GT:EV:GQ:PE_GQ:PE_GT:SR_GQ:SR_GT	0/0:PE,SR:99:99:0:99:0	0/0:PE,SR:99:99:0:99:0	0/1:SR:0:99:0:0:1	0/0:PE,SR:99:99:0:2:0	0/0:PE,SR:99:99:0:2:0
chr1	21427498	CPX_chr1_54	N	<CPX>	733	PASS	ALGORITHMS=manta;CHR2=chr1;CPX_INTERVALS=DUP_chr1:21427498-21427959,INV_chr1:21427498-21480073,DEL_chr1:21480073-21480419;CPX_TYPE=dupINVdel;END=21480419;EVIDENCE=PE;PREDICTED_LOF=NBPF3;PREDICTED_NONCODING_BREAKPOINT=DNase,Tommerup_TADanno;PREDICTED_NONCODING_SPAN=DNase;SVLEN=52921;SVTYPE=CPX;AN=8;AC=4;AF=0.499656;N_BI_GENOS=2911;N_HOMREF=51;N_HET=2811;N_HOMALT=49;FREQ_HOMREF=0.0175198;FREQ_HET=0.965648;FREQ_HOMALT=0.0168327;MALE_AN=2894;MALE_AC=1453;MALE_AF=0.502073;MALE_N_BI_GENOS=1447;MALE_N_HOMREF=19;MALE_N_HET=1403;MALE_N_HOMALT=25;MALE_FREQ_HOMREF=0.0131306;MALE_FREQ_HET=0.969592;MALE_FREQ_HOMALT=0.0172771;FEMALE_AN=2906;FEMALE_AC=1445;FEMALE_AF=0.497247;FEMALE_N_BI_GENOS=1453;FEMALE_N_HOMREF=32;FEMALE_N_HET=1397;FEMALE_N_HOMALT=24;FEMALE_FREQ_HOMREF=0.0220234;FEMALE_FREQ_HET=0.961459;FEMALE_FREQ_HOMALT=0.0165175	GT:EV:GQ:PE_GQ:PE_GT:SR_GQ:SR_GT	0/1:PE:93:93:1:99:0	0/1:PE:79:79:1:99:0	0/1:PE:33:33:1:6:0	0/1:PE,SR:39:39:1:99:0	0/1:PE,SR:39:39:1:99:0
chr1	48963084	INS_chr1_688	N	<INS:ME:LINE1>	526	HIGH_SR_BACKGROUND	ALGORITHMS=melt;CHR2=chr1;END=48963135;EVIDENCE=SR;PREDICTED_INTRONIC=AGBL4;PREDICTED_NONCODING_BREAKPOINT=Tommerup_TADanno;SVLEN=5520;SVTYPE=INS;AN=8;AC=1;AF=0.06338;N_BI_GENOS=2911;N_HOMREF=2544;N_HET=365;N_HOMALT=2;FREQ_HOMREF=0.873926;FREQ_HET=0.125386;FREQ_HOMALT=0.000687049;MALE_AN=2894;MALE_AC=177;MALE_AF=0.061161;MALE_N_BI_GENOS=1447;MALE_N_HOMREF=1271;MALE_N_HET=175;MALE_N_HOMALT=1;MALE_FREQ_HOMREF=0.878369;MALE_FREQ_HET=0.12094;MALE_FREQ_HOMALT=0.000691085;FEMALE_AN=2906;FEMALE_AC=192;FEMALE_AF=0.06607;FEMALE_N_BI_GENOS=1453;FEMALE_N_HOMREF=1262;FEMALE_N_HET=190;FEMALE_N_HOMALT=1;FEMALE_FREQ_HOMREF=0.868548;FEMALE_FREQ_HET=0.130764;FEMALE_FREQ_HOMALT=0.000688231	GT:EV:GQ:PE_GQ:PE_GT:SR_GQ:SR_GT	0/0:PE,SR:99:99:0:99:0	0/0:PE,SR:99:99:0:99:0	0/0:PE,SR:99:99:0:99:0	0/1:SR:0:99:0:0:1	0/1:SR:0:99:0:0:1
chr1	180540234	CPX_chr1_251	N	<CPX>	999	UNRESOLVED	ALGORITHMS=manta;CHR2=chr1;CPX_INTERVALS=DEL_chr1:180540234-181074767,INV_chr1:181074767-181074938;CPX_TYPE=delINV;END=181074952;EVIDENCE=PE,SR;PREDICTED_LOF=KIAA1614,MR1,STX6,XPR1;PREDICTED_NONCODING_BREAKPOINT=Tommerup_TADanno;PREDICTED_NONCODING_SPAN=DNase,Enhancer;SVLEN=534718;SVTYPE=CPX;UNRESOLVED_TYPE=POSTHOC_RD_GT_REJECTION;AN=8;AC=3;AF=0.251804;N_BI_GENOS=2911;N_HOMREF=1559;N_HET=1238;N_HOMALT=114;FREQ_HOMREF=0.535555;FREQ_HET=0.425283;FREQ_HOMALT=0.0391618;MALE_AN=2894;MALE_AC=724;MALE_AF=0.250173;MALE_N_BI_GENOS=1447;MALE_N_HOMREF=784;MALE_N_HET=602;MALE_N_HOMALT=61;MALE_FREQ_HOMREF=0.541811;MALE_FREQ_HET=0.416033;MALE_FREQ_HOMALT=0.0421562;FEMALE_AN=2906;FEMALE_AC=736;FEMALE_AF=0.253269;FEMALE_N_BI_GENOS=1453;FEMALE_N_HOMREF=770;FEMALE_N_HET=630;FEMALE_N_HOMALT=53;FEMALE_FREQ_HOMREF=0.529938;FEMALE_FREQ_HET=0.433586;FEMALE_FREQ_HOMALT=0.0364763	GT:EV:GQ:PE_GQ:PE_GT:SR_GQ:SR_GT	0/0:PE,SR:99:99:0:99:0	0/1:PE,SR:41:26:1:41:1	1/1:PE,SR:89:33:1:89:2	0/0:PE,SR:99:99:0:99:0	0/0:PE,SR:99:99:0:99:0